Scalp Hypothermia for the Prevention of Chemotherapy-Induced Alopecia in Breast Cancer

    February 2024 in “ Journal of Modern Oncology
    Nikolai A. Ognerubov, Sergei V. Barsukov
    TLDR Scalp cooling helps prevent hair loss during chemotherapy for breast cancer.
    The study evaluated the efficacy of scalp hypothermia (SHT) in preventing chemotherapy-induced alopecia in 75 breast cancer patients. Conducted from 2016 to 2023, the study found that SHT, using the Orbis II device, resulted in complete hair preservation in 57.3% of patients. Grade 1 and 2 alopecia were observed in 25.4% and 12% of patients, respectively. Side effects were minimal, with 16% experiencing cold sensations or headaches, and 3 patients discontinuing due to intolerance. No scalp metastases were reported. Overall, SHT was deemed effective in reducing alopecia, aiding in patients' psychological and social well-being.
    Discuss this study in the Community →

    Research cited in this study

    20 / 20 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    1 / 1 results